Sample Page
Author:
Valitor, Inc.
Posted Date:
May 13, 2026
Valitor to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
Valitor, Inc.
May 13, 2026
Valitor Presents Preclinical Data Demonstrating Superior Durability with Six-month Treatment Protocol of VLTR-559 to Treat Wet AMD
Valitor, Inc.
May 4, 2026
Valitor to Participate in the 25th Annual Needham Virtual Healthcare Conference
Valitor, Inc.
April 9, 2026
Valitor Announces Oral Presentation at the Upcoming Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting
Valitor, Inc.
April 7, 2026
